Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (IgG(L)-scFv) is formed by an IgG and two scFv moieties. The scFv fragments from an anti-FGF2 antibody are fused to the C terminus of an anti-VEGF IgG light (L) chains, or vice versa. It is a type of appended IgGs, which is bispecific and tetravalent (2+2 antigen-binding valency). This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Hepatocellular cancer (HCC); Breast cancer; Colon cancer; Lung cancer; Glioma cancer therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-FGF2 x Human Anti-VEGF Bispecific Antibody (IgG(L)-scFv) (IGLFV-H326). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS